title: Reply: To PMID 23564522.
authors: Department of Gastroenterology and Hepatology, Department of Liver Disease Control, Tokyo Medical and Dental University, Tokyo, Japan.
authors: Yasuhiro
authors: Y
authors: Asahina
authors: Kaoru
authors: K
authors: Tsuchiya
authors: Namiki
authors: N
authors: Izumi
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology*; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000453:epidemiology*; D008297:Male; D000509:alpha-Fetoproteins / Q000378:metabolism*
chemical_list: D000998:Antiviral Agents; D000509:alpha-Fetoproteins; D007372:Interferons